n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Alzheimer Disease in 2 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherny, RA | 1 |
| Legg, JT | 1 |
| McLean, CA | 1 |
| Fairlie, DP | 1 |
| Huang, X | 1 |
| Atwood, CS | 1 |
| Beyreuther, K | 1 |
| Tanzi, RE | 1 |
| Masters, CL | 1 |
| Bush, AI | 1 |
| Ho, LH | 1 |
| Ratnaike, RN | 1 |
| Zalewski, PD | 1 |
2 other studies available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Alzheimer Disease
| Article | Year |
|---|---|
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Copper; Egtazic Acid; Ethylenedia | 1999 |
Involvement of intracellular labile zinc in suppression of DEVD-caspase activity in human neuroblastoma cells.
Topics: Alzheimer Disease; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Chelating Agents; Coumarins; | 2000 |